Methods of identifying agents that diminish cellular toxicity associated with an α-synuclein polypeptide of parkinson's disease in yeast
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 27, 2014
Grant Date -
Apr 4, 2013
app pub date -
Mar 13, 2012
filing date -
Dec 4, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Methods of screening candidate agents to identify lead compounds for the development of therapeutic agents for the treatment of a neurodegenerative disease, such as Huntington's Disease and Parkinson's Disease and methods for identifying a mutation in, or changes in expression of, a gene associated with neurodegenerative disease, such as Huntington's Disease and Parkinson's Disease, are provided.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully